Latest News - Pharm Tech Europe
  • Subscribe / Renew
  • E-directory
  • Past Issues
  • About Us
  • Contact Us
  • Sign Up: e-Newsletter
 

ADVERTISEMENT

Sep 6, 2010

Latest News

Extending antibody shelf life

30 July 2009

Researchers working on extending the shelf life of antibody drugs may find help in a computer model developed by a research team at MIT (MA, USA).

Sanofi Pasteur boosts vaccine portfolio

30 July 2009

Sanofi aventis's vaccines division, Sanofi Pasteur (France), has acquired the ShanH subsidiary of Mërieux Alliance, which will give Sanofi Pasteur a majority stake in the Indian based vaccine producer Shantha Biotechnics.

Flu vaccines fast tracked in the EU

30 July 2009

The EMEA is racing to fast track the review of data on H1N1 pandemic vaccines before the start of the Northern hemisphere flu season, which is expected to begin in September.

Collaboration to tackle asthma

24 July 2009

A new collaboration in the UK has been established to identify treatments that will stop asthma from worsening rather than simply alleviating the symptoms.

118% rise in medicines detained by EU customs

24 July 2009

Statistics published by the European Commission show a 118% increase in the number of medicines detained by EU customs in 2008 compared with 2007.

US API manufacturing facility to be dedicated

24 July 2009

A new, large-scale manufacturing facility offering western-based API supply will be dedicated on 30 July 2009 in Germantown (WI, USA) by Cambridge Major Laboratories.

Final guidance given on listing drug-substance impurities

24 July 2009

The FDA has posted the final version of its Guidance for Industry, ANDAs: Impurities in Drug Substances.

Microneedles moving into the market?

22 July 2009

Microneedle technology is moving closer to commercialization, according to research by Greystone Associates, as devices are being investigated by several companies lured by the potential advantages of extending the reach of transdermal drug delivery and the ability to meet the trend towards self administration.

EC approves Pfizer's Wyeth take over

21 July 2009

Pfizer's proposed acquisition of Wyeth appears to be on track after the European Commission (EC) issued its thumbs up under the EU's Merger Regulation; however, the approval came with a price as Pfizer has been told to divest several types of animal operations in the European Economic Area.

Boost your marketing campaigns
Survey
Should a drug label state how the medicine compares with similar treatments?
Yes
No
Yes
53%
No
47%
View Results
Click here